There are currently three SARS-CoV-2 vaccines that have been authorized for emergency use by the U.S. FDA, and all three are currently being administered in Virginia: Pfizer/BioNTech, Moderna, and Janssen. As of late April, the Pfizer/BioNTech vaccine is authorized for those 16+ years old, Moderna for 18+ years old, and Janssen for those 18+ years old.
There are currently no vaccines approved for use in children under 16, though on 9 April 2021 Pfizer requested an amendment to its authorization to extend to the 12-15 year old age group.
In March 2021, Pfizer announced it began testing its vaccine in children aged 5 to 11 years, with plans to expand to 2 to 5 years and then to 6 months to 2 years. Also in March 2021, Moderna announced a trial in children 6 months to 12 years of age. In early April 2021, Janssen announced it was testing its vaccine in the 12-17 age group.
Will at least one SARS-CoV-2 vaccine be granted emergency use authorization by the U.S. FDA for children under 12 years old before 1 September 2021?
This question resolves on the basis of a press announcement by the FDA stating that a SARS-CoV-2 vaccine has been authorized for children under 12 years of age. For this to resolve positively, such an authorization should cover an age group of at least seven years — for instance, an authorization for 5-11 year olds (inclusive) would count but 9-11 year olds (inclusive) would not.